Medicinal Chemistry · 2006 · 20 citations · 0 references
PharmacyMedicinal ChemistryPharmacologyBioisosterismDrug DesignDrug DiscoveryAnalgesic PharmacologyBioisosteric DesignBioisosteric ReplacementLead Compound DesignLead DiscoveryStructure-activity Relationship AnalysisAnalgesic Anti-inflammatory PharmacologyAnti-inflammatory ActivityAnti-inflammatory ResponseChemical Synthesis Of AnaloguesLead Optimization By BioisosterismNovel Antibacterial AgentsNovel Antibacterial Drug DiscoveryPharmacological Pain Relief
Pain and inflammation are simultaneous responses in bacterial infections. In current clinical practice, two groups of agents like antibacterial and non-steroidal anti-inflammatory drugs (NSAID's) are prescribed simultaneously. Regrettably, none of the drug possesses these activities in a single component. Exploiting the bioisosterism concept, we have documented that 2-phenyl-3-substituted quinazolines, 2,3-disubstituted quinazolines, 2-methyl-3-substituted quinazolin-4-(3H)-ones and 2-methylthio-3-substituted quinazolin-4-(3H)-ones exhibited good analgesic and anti-inflammatory activities. The present work is an extension of our ongoing efforts towards the development and identification of lead molecules by bioisostere concept, for which we designed some of 2-methylthio-3-substituted-5,6-dimethylthieno[2,3-d] pyrimidin-4(3H)-ones. The title compounds were investigated for analgesic, anti-inflammatory and antibacterial activities. While the test compounds exhibited significant activity, the compounds (6-9) showed more potent analgesic activity, and the compounds (8, 9) showed anti-inflammatory activity comparable to the reference standard diclofenac.